Ranitidine Injection USP (2020-08-27)
- Starting date:
- August 27, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73829
Last updated:
2020-08-28
Summary
-
Product:
Ranitidine Injection USP
Reason
The affected lots may contain particles.
Depth of distribution
Healthcare establishments
Affected products
Ranitidine Injection USP
DIN, NPN, DIN-HIM
DIN 02256711
Dosage form
Solution
Strength
Ranitidine (Ranitidine Hydrochloride) 25 mg/mL
Lot or serial number
JX9941
JS7049
JN6154
JV4206
JV0519
JS1506
JP1270
Companies
- Recalling Firm
-
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA